InvestSMART

Imagion Biosystems Limited (ASX: IBX) - Announcements

- Current share price for IBX : $0.005

ASX company news and announcements for Imagion Biosystems Limited (IBX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imagion Biosystems Limited (IBX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imagion Biosystems Limited (IBX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imagion Biosystems Limited (IBX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Consolidation/Split - IBX 13 Oct 2023 11:58AM $0.014 $0.005 fallen by 64.29%
$4 Notice of Extraordinary General Meeting/Proxy Form 13 Oct 2023 9:15AM $0.016 $0.005 fallen by 68.75%
$4 Imagion presents ovarian cancer data at AACR conference 9 Oct 2023 9:37AM $0.017 $0.005 fallen by 70.59%
$4 Imagion Biosystems Investor Newsletter 6 Oct 2023 12:21PM $0.017 $0.005 fallen by 70.59%
$4 Notification of cessation of securities - IBX 4 Oct 2023 10:21AM $0.014 $0.005 fallen by 64.29%
$4 Investor update 2 Oct 2023 10:15AM $0.014 $0.005 fallen by 64.29%
$4 Notification regarding unquoted securities - IBX 20 Sep 2023 12:47PM $0.014 $0.005 fallen by 64.29%
$4 Notification of cessation of securities - IBX 20 Sep 2023 12:41PM $0.014 $0.005 fallen by 64.29%
$4 2022 R&D Tax Refund 19 Sep 2023 9:07AM $0.014 $0.005 fallen by 64.29%
$4 Half-Year Results Release 30 Aug 2023 8:10AM $0.016 $0.005 fallen by 68.75%
$4 Half-Year Financial Report 30 Aug 2023 8:09AM $0.016 $0.005 fallen by 68.75%
$4 Appendix 4D 30 Aug 2023 8:09AM $0.016 $0.005 fallen by 68.75%
$4 Cleansing Statement under Section 708A(12C)(e) 25 Aug 2023 9:41AM $0.017 $0.005 fallen by 70.59%
$4 Notification regarding unquoted securities - IBX 25 Aug 2023 9:40AM $0.017 $0.005 fallen by 70.59%
$4 Notification regarding unquoted securities - IBX 25 Aug 2023 9:35AM $0.017 $0.005 fallen by 70.59%
$4 Convertible Note Investment 25 Aug 2023 9:32AM $0.017 $0.005 fallen by 70.59%
$4 Proposed issue of securities - IBX 24 Aug 2023 4:09PM $0.016 $0.005 fallen by 68.75%
$4 MOU to develop early pancreatic cancer diagnosis platform 11 Aug 2023 10:27AM $0.014 $0.005 fallen by 64.29%
$4 Letter to Shareholders from the CEO, Dr. Isaac Bright 31 Jul 2023 11:32AM $0.015 $0.005 fallen by 66.67%
$4 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2023 11:30AM $0.015 $0.005 fallen by 66.67%
$4 Application for quotation of securities - IBX 21 Jul 2023 11:14AM $0.018 $0.005 fallen by 71.43%
$4 Transition of Chairman 17 Jul 2023 10:14AM $0.022 $0.005 fallen by 77.27%
$4 Application for quotation of securities - IBX 14 Jul 2023 1:59PM $0.021 $0.005 fallen by 76.19%
$4 Non-renounceable Entitlement Offer Shortfall 14 Jul 2023 1:58PM $0.021 $0.005 fallen by 76.19%
$4 Response to ASX Price Query 12 Jul 2023 12:48PM $0.031 $0.005 fallen by 83.87%

226 - 250 of 695 results

Page 10 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.